Oragenics Inc  

(Public, NYSEAMERICAN:OGEN)   Watch this stock  
Find more results for OGEN
-0.009 (-3.28%)
Dec 15 - Close
NYSEAMERICAN real-time data - Disclaimer
Currency in USD
Range 0.27 - 0.30
52 week 0.27 - 0.85
Open 0.30
Vol / Avg. 392,313.00/142,677.00
Mkt cap 13.33M
P/E     -
Div/yield     -
EPS -0.16
Shares 49.27M
Beta 1.28
Inst. own 39%

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -170.74% -168.47%
Return on average equity - -220.80%
Employees 12 -
CDP Score - -


4902 Eisenhower Blvd Ste 125
TAMPA, FL 33634-6342
United States - Map
+1-813-2867900 (Phone)
+1-813-2867904 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Oragenics, Inc. develops, markets and sells probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora. The Company is focused on offering antibiotics against infectious disease and on developing treatments for oral mucositis. It is engaged in developing its antibiotic product candidate, MU1140, as well as other homolog antibiotic product candidates; researching AG013 in connection with the treatment of Oral Mucositis; commercializing its ProBiora3 probiotic products, and has other product candidates for out licensing or partnering. MU1140 is an antibiotic that is produced by the parent of the SMaRT strain. ProBiora3 is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145. LPT3-04 is a compound, which is consumed in the human diet in small amounts and results in dose-dependent weight loss in experimental animal models.

Officers and directors

Frederick W. Telling Ph.D. Independent Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Alan F. Joslyn Ph.D. President, Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Michael O'Keefe Sullivan CPA Chief Financial Officer, Treasurer, Secretary
Age: 58
Bio & Compensation  - Reuters
Alan William Dunton M.D. Independent Director
Age: 61
Bio & Compensation  - Reuters
Robert C Koski Independent Director
Age: 56
Bio & Compensation  - Reuters
Charles L. Pope CPA Independent Director
Age: 63
Bio & Compensation  - Reuters